Literature DB >> 21824459

Optimizing clinical outcomes across domains of life in adolescents and adults with ADHD.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824459     DOI: 10.4088/JCP.10063ah1

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


× No keyword cloud information.
  4 in total

Review 1.  Lisdexamfetamine in the treatment of adolescents and children with attention-deficit/hyperactivity disorder.

Authors:  Jadwiga Najib
Journal:  Adolesc Health Med Ther       Date:  2012-05-08

2.  Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate.

Authors:  Peter Nagy; Alexander Häge; David R Coghill; Beatriz Caballero; Ben Adeyi; Colleen S Anderson; Vanja Sikirica; Esther Cardo
Journal:  Eur Child Adolesc Psychiatry       Date:  2015-05-22       Impact factor: 4.785

Review 3.  Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder.

Authors:  David R Coghill; Tobias Banaschewski; César Soutullo; Matthew G Cottingham; Alessandro Zuddas
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-04-20       Impact factor: 4.785

Review 4.  Implementation of independent nurse prescribing in UK mental health settings: focus on attention-deficit/hyperactivity disorder.

Authors:  Lisa Mangle; Paula Phillips; Mark Pitts; Cathy Laver-Bradbury
Journal:  Atten Defic Hyperact Disord       Date:  2014-04-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.